Published in J Thromb Haemost on February 01, 2005
Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med (2010) 1.95
Diagnosis and treatment of deep-vein thrombosis. CMAJ (2006) 1.44
Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecology. J Turk Ger Gynecol Assoc (2011) 0.83
Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. J Acquir Immune Defic Syndr (2013) 0.75
Large D-Dimer Fluctuation in Normal Pregnancy: A Longitudinal Cohort Study of 4,117 Samples from 714 Healthy Danish Women. Obstet Gynecol Int (2016) 0.75
Perinatal determinants of D-dimer levels in a cross-sectional study of low risk pregnant women. Obstet Med (2016) 0.75
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): protocol and statistical analysis plan for a randomized controlled trial. Wellcome Open Res (2016) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2009) 4.95
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG (2014) 3.48
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost (2007) 2.86
On the molecular weight of myosin. II. Biochemistry (1966) 2.85
Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost (2004) 2.71
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J (2000) 2.45
Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study. Eur J Clin Nutr (2006) 2.11
Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost (1994) 2.10
NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost (2014) 2.05
Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet (1991) 1.99
Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) (2001) 1.87
Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron (1995) 1.82
Maternal height and external pelvimetry to predict cephalopelvic disproportion in nulliparous African women: a cohort study. BJOG (2000) 1.75
Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet (1996) 1.54
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost (2006) 1.54
Pregnancy in a patient with treated Wilson's disease: a case report. Am J Obstet Gynecol (1990) 1.51
New oral antithrombotics: a need for laboratory monitoring. Against. J Thromb Haemost (2010) 1.48
Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects. J Thromb Haemost (2007) 1.45
Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost (2003) 1.45
Spatial interaction between neighbouring counties: cancer mortality data in Valencia Spain. Biometrics (1995) 1.43
Antibiotics for preterm premature rupture of membranes. Cochrane Database Syst Rev (2001) 1.42
[Recurrent respiratory infections in patients with chronic obstructive bronchitis: medical treatment and costs]. Rev Mal Respir (1996) 1.41
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost (2008) 1.41
Prolonged anti-Xa activity due to enoxaparin at the end of pregnancy. Anaesth Intensive Care (2014) 1.39
Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev (2003) 1.38
[Pleural empyema caused by Cryptococcus neoformans in a patient with liver cirrhosis]. Gastroenterol Hepatol (1996) 1.38
Rectification properties and Ca2+ permeability of glutamate receptor channels in hippocampal cells. Eur J Neurosci (1994) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
Increased recall rate at screening for congenital hypothyroidism in breast fed infants born to iodine overloaded mothers. Arch Dis Child (1988) 1.29
Sociodemographic characteristics and HIV risk behaviour patterns of male sex workers in Madrid, Spain. AIDS Care (2001) 1.29
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost (2008) 1.27
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology (2000) 1.20
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Biochemical oscillations in "controlled" systems. Biophys J (1967) 1.11
In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. Exp Neurol (2001) 1.10
Subacute uterine inversion: description of a novel replacement technique using the obstetric ventouse. BJOG (2006) 1.10
Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil (2008) 1.10
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res (2011) 1.10
Time-dependent fluorescence depolarization and lifetime studies of myosin subfragment-one in the presence of nucleotide and actin. J Supramol Struct (1975) 1.09
Multicenter, randomized, controlled trial of delayed pushing for nulliparous women in the second stage of labor with continuous epidural analgesia. The PEOPLE (Pushing Early or Pushing Late with Epidural) Study Group. Am J Obstet Gynecol (2000) 1.09
Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol (1989) 1.08
Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke (2001) 1.08
Conformational changes in the molecular control of muscle contraction. Biochemistry (1969) 1.08
Induction of labour for suspected fetal macrosomia. Cochrane Database Syst Rev (2000) 1.07
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant (2011) 1.05
Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin Microbiol Infect (2011) 1.05
Molecular subtyping of Neisseria meningitidis serogroup B: comparison of five methods. J Clin Microbiol (1996) 1.05
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia (2009) 1.05
Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost (1995) 1.04
Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry (2000) 1.03
Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci (1997) 1.02
Membrane sweeping for induction of labour. Cochrane Database Syst Rev (2005) 1.02
Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence. J Neurosci (1994) 1.01
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation. Eur Respir J (2002) 1.01
GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J Comp Neurol (2001) 1.01
A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res (1999) 1.00
Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells. J Neurosci (1998) 1.00
A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation. J Clin Invest (1992) 1.00
Can we improve the diagnosis of rupture of membranes? The value of insulin-like growth factor binding protein-1. BJOG (2006) 0.99
Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 0.98
Le Fort I osteotomy approach to the skull base. Laryngoscope (1990) 0.98
Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem (1993) 0.98
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism. Thromb Haemost (2001) 0.98
D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res (1993) 0.97
Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex (2012) 0.97
Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology (2002) 0.97
Mechanical methods for induction of labour. Cochrane Database Syst Rev (2001) 0.97
HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol (2003) 0.97
Should the D-dimer cut-off value be increased in elderly patients suspected of pulmonary embolism? Thromb Haemost (2001) 0.97
Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann N Y Acad Sci (2002) 0.97
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. J Endocrinol (2002) 0.96
Diagnosis of anal sphincter tears by postpartum endosonography to predict fecal incontinence. Obstet Gynecol (2000) 0.96
Left internal mammary artery to innominate vein fistula complicating pacemaker insertion. Treatment with endovascular transarterial coil embolization. J Cardiovasc Surg (Torino) (1999) 0.96
Sequential combined spinal-epidural anesthesia for cesarean section in a woman with a double-outlet right ventricle. Acta Anaesthesiol Scand (2004) 0.95
Cervical cancer in pregnant women: laparoscopic evaluation before delaying treatment. Eur J Gynaecol Oncol (2005) 0.95
Myo-inositol transport in Aerobacter aerogenes. Biochim Biophys Acta (1972) 0.95
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol Ther (1999) 0.94
The prevalence of Dirofilaria immitis in Gran Canaria, Canary Islands, Spain (1994-1996). Vet Parasitol (1998) 0.93
Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf (2001) 0.93
Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett (1994) 0.93
Transport of cyclitols by a proton symport in Klebsiella aerogenes. Eur J Biochem (1977) 0.92
Serum CA 125 in epithelial ovarian cancer. A longitudinal study. Br J Obstet Gynaecol (1987) 0.92
Rare bleeding disorders. Haemophilia (2008) 0.92
Histochemical differentiation of Dirofilaria immitis, Dirofilaria repens and Acanthocheilonema dracunculoides microfilariae by staining with a commercial kit, Leucognost-SP. Vet Parasitol (2001) 0.92
Cervical length as a prognostic factor for preterm delivery in twin-to-twin transfusion syndrome treated by fetoscopic laser coagulation of chorionic plate anastomoses. Ultrasound Obstet Gynecol (2005) 0.92
Intracervical prostaglandins for induction of labour. Cochrane Database Syst Rev (2008) 0.91
Fused eyelids in the extremely premature infant: multivariate analysis of survival and outcome. Am J Perinatol (1992) 0.91
VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem (1996) 0.91